Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
46 hedge funds and large institutions have $55.1M invested in Neos Therapeutics, Inc in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 7 reducing their positions, and 6 closing their positions.
286% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 47 → 46 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
18% less capital invested
Capital invested by funds: $66.8M → $55.1M (-$11.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$5.03M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.99M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$697K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$620K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$568K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.35M |
| 2 |
SCM
Sio Capital Management
New York
|
-$4.22M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$3.63M |
| 4 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$1.62M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$195K |
NEOS Hedge Fund Activity: Q2 2016 in Review
46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2016, worth a combined $55.1M — down 18% from $66.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NEOS and 5 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 27 added.
The largest buyer was Perceptive Advisors, adding an estimated $5.03M. The largest seller was Emerald Mutual Fund Advisers Trust, exiting entirely with an estimated $4.35M sold.
- 46 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2016, down from 47 in Q1 2016.
- Funds reported $55.1M of Neos Therapeutics, Inc stock for Q2 2016, down 18% quarter-over-quarter.
- 5 funds opened new Neos Therapeutics, Inc positions in Q2 2016 and 6 closed out, a net change of -1 holder.
- The largest Neos Therapeutics, Inc buyer in Q2 2016 was Perceptive Advisors, an estimated $5.03M added.
- The largest Neos Therapeutics, Inc seller in Q2 2016 was Emerald Mutual Fund Advisers Trust, an estimated $4.35M sold.
Based on aggregated 13F filings for Q2 2016.